Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma, T-Cell, Peripheral 4Lymphoma 4Hematologic Neoplasms 2Recurrence 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Leukemia 1Bone Marrow Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 75fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 59Mycophenolic Acid 53Tacrolimus 51Whole-Body Irradiation 48Busulfan 42Antilymphocyte Serum 40Cyclosporine 38Filgrastim 32fludarabine 31Methotrexate 30Melphalan 29Radiotherapy 22Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Etoposide 16Sirolimus 14Alemtuzumab 13Flow Cytometry 12Cyclosporins 12thymoglobulin 11Granulocyte Colony-Stimulating Factor 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 8Thiotepa 8Rituximab 8Therapeutics 7Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × darinaparsin × Lymphoid × Clear all
NCT00592046 2012-07-19

A Phase I Trial of ZIO-101 in Hematologic Cancers

Alaunos Therapeutics

Phase 1 Completed
12 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Recurrence, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡